About Amgen Astellas BioPharma
Corporate Profile
Press Room
Mission and Vision
Message from Representative Director
Corporate History
Clinical Development Programs
Supplier Procurement Guidelines
Information
Contact
日本語
About Amgen Astellas BioPharma
Corporate Profile
Press Room
Mission and Vision
Message from Representative Director
Corporate History
Clinical Development Programs
Supplier Procurement Guidelines
Information
Contact
日本語
Information
Back to Information Overview
【Press Release】New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes
September 15, 2017
To read more, please visit Amgen's news site.
Back to Information Overview